Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SINTX TechnologiesSINT +3.31%29 Days Sales Outstanding is 70.73 as of Jun. 2026, which is 33% below its 10-year median of 105.69. GuruFocus rates SINT with a GF Score™ of 29/100 and a GF Value™ of $0.27 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 810 Medical Devices & Instruments companies, SINTX Technologies ranks worse than 60.49% on this metric.
The historical rank and industry rank for SINTX Technologies's Days Sales Outstanding or its related term are showing as below:
SINT'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.07 Med: 105.69 Max: 2887.34
Current: 73.2
During the past 13 years, SINTX Technologies's highest Days Sales Outstanding was 2887.34. The lowest was 43.07. And the median was 105.69.
SINT's Days Sales Outstanding is ranked worse than 60.49% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.21
vs SINT: 73.20
SINTX Technologies's Days Sales Outstanding
declined
from Jun. 2025 (88.51) to Jun. 2026 (70.73).
SINTX Technologies (NAS:SINT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
SINTX Technologies Days Sales Outstanding Related Terms
SINTX Technologies Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for SINTX Technologies's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SINT vs PMI, HSCS, CODX: Days Sales Outstanding Comparison
For the Medical Devices subindustry, SINTX Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SINTX Technologies Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where SINTX Technologies's Days Sales Outstanding falls into.
SINTX Technologies Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SINTX Technologies (SINT) has a Days Sales Outstanding of 70.73 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on SINTX Technologies and its competitors. This is 33% below median its historical median of 105.69. Over the past decade, SINTX Technologies' Days Sales Outstanding has ranged from 43.07 to 2,887.34. According to the industry distribution chart, SINTX Technologies ranks #490 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 60.5%.
Is SINTX Technologies' Days Sales Outstanding too high?
SINTX Technologies' current Days Sales Outstanding of 70.73 is 33% below median its 10-year median of 105.69. Over the past 10 years, this metric has ranged from a low of 43.07 to a high of 2,887.34. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.21. SINTX Technologies' value of 70.73 is 8.5% above this industry median. Based on the distribution chart, SINTX Technologies ranks #490 out of 810 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SINTX Technologies has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' Days Sales Outstanding compare to PMI and HSCS?
According to the Medical Devices & Instruments industry distribution chart, SINTX Technologies ranks #490 out of 810 companies for Days Sales Outstanding. This places SINTX Technologies in the lower half of its industry. The industry median Days Sales Outstanding is 65.21. SINTX Technologies' value of 70.73 is 8.5% above this benchmark. Historically, SINTX Technologies' own Days Sales Outstanding has ranged from 43.07 to 2,887.34 over the past decade. While the company's 10-year median is 105.69 vs. the industry median of 65.21, SINTX Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.21, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SINTX Technologies's current Days Sales Outstanding of 70.73 is 8.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on SINTX Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SINTX Technologies's current Days Sales Outstanding is 70.73, which is 33% below median its own 10-year median of 105.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.27, compared to a current price of $1.55 — trading 474.1% above its estimated fair value. The current Days Sales Outstanding is 70.73, which is 33% below median its 10-year median of 105.69 and 8.5% above the Medical Devices & Instruments industry median of 65.21. SINTX Technologies' overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For SINTX Technologies (SINT), the current Days Sales Outstanding is 70.73 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SINTX Technologies (SINT) Overvalued in 2026?
Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued.
The current stock price of $1.55 is trading 474.1% above its estimated GF Value™ of $0.27.
GuruFocus considers SINTX Technologies to be Significantly Overvalued.
Key valuation signals for SINT:
Days Sales Outstanding: 70.73 (33% below median its 10-year median of 105.69)
GF Value™: $0.27 vs. price of $1.55 (474.1% above fair value)
Industry Position: 8.5% above the Medical Devices & Instruments median (#490 of 810)
No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
29GF Score
Get the complete analysis for SINT
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SINT has been successfully added to your 
